Instil Bio, Inc.
TIL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $137 | $113 | $125 |
| - Cash | $6 | $8 | $15 | $9 |
| + Debt | $85 | $0 | $87 | $87 |
| Enterprise Value | – | $130 | $185 | $203 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$20 | -$27 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$14 | -$21 | -$28 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.01 | -3.24 | -4.32 | -1.82 |
| % Growth | 38% | 25% | -137.4% | – |
| Operating Cash Flow | -$11 | -$15 | -$4 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$11 | -$15 | -$4 | -$11 |